Circadian blood pressure rhythm as a possible key target of SGLT2 inhibitors used for the treatment of Type 2 diabetes

Hypertens Res. 2016 Jun;39(6):396-8. doi: 10.1038/hr.2016.1. Epub 2016 Jan 28.

Authors

Kouichi Tamura¹, Hiromichi Wakui¹, Kengo Azushima¹, Kazushi Uneda¹, Satoshi Umemura¹

Affiliation

¹ Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

PMID: 26818654
DOI: 10.1038/hr.2016.1

No abstract available

MeSH terms

Blood Pressure / drug effects*
Circadian Rhythm / drug effects*
Diabetes Mellitus, Type 2 / drug therapy*
Diabetes Mellitus, Type 2 / physiopathology
Humans
Hypoglycemic Agents / pharmacology*
Hypoglycemic Agents / therapeutic use
Sodium-Glucose Transporter 2 Inhibitors*

Substances

Hypoglycemic Agents
Sodium-Glucose Transporter 2 Inhibitors